Characterisation of Sulf1/Sulf2 functional heterogeneity has clinical implications not only in angiogenic cell signalling but also in the prevention or reduction of thrombosis and atherosclerosis, which requires further studies. The gene discussed is SULF2; the disease is atherosclerosis.